Imunon IMNN
NASDAQ IMNN
$1.63 +0.05 (+3.14%)
As of: Aug 21, 2026 · 12:38 PM EDT

Imunon (IMNN) Receivables - Other (2013 - 2014)

Imunon's (IMNN) quarterly Receivables - Other came in at $371000.0 in Q2 2014, little changed YoY from $371000.0 in Q2 2013, and little changed on a QoQ basis from $371000.0 in Q1 2014.

Imunon (IMNN) Receivables - Other (2013 - 2014) Analysis & Trends

Imunon (IMNN) has 2 years of Receivables - Other data on file, last reported at $371000.0 in Q2 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.71 Bn 131.86 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.55 Bn 78.55 Bn 3.93 Bn
3 Argenx Se 65.26 Bn 60.07 Bn 1.37 Bn
4 Moderna 59.81 Bn 54.67 Bn 52.00 Mn
5 BeOne Medicines 42.16 Bn 37.06 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.87 Bn 28.56 Bn 992.69 Mn
7 BioNTech SE 28.13 Bn 9.74 Bn 668.28 Mn
8 Insmed 27.53 Bn 26.37 Bn 358.27 Mn
9 Royalty Pharma 27.31 Bn 26.47 Bn -
10 Imunon 8.53 Mn 8.53 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2014 371,000.00
Jun 30, 2014 371,000.00
Mar 31, 2014 371,000.00
Mar 31, 2014 371,000.00
Sep 30, 2013 371,000.00
Sep 30, 2013 371,000.00
Jun 30, 2013 371,000.00
Jun 30, 2013 371,000.00